Hunchback activators encompass a distinct category of chemical compounds that directly or indirectly stimulate the functional activity of the Hunchback protein, a transcription factor critical in early embryonic development in Drosophila and other species. These activators function through various cellular pathways to increase the activity of Hunchback without altering its expression levels. For instance, certain small molecule activators may bind to co-factors that associate with Hunchback, thereby stabilizing the transcriptional complex and enhancing its ability to drive the expression of target genes. Others might influence post-translational modifications of the protein; for example, specific phosphatases can lead to an increased phosphorylation state of Hunchback, subsequently augmenting its DNA binding affinity and transcriptional activity. Additionally, molecules that modulate the cellular concentration of ions such as calcium could indirectly enhance Hunchback activity by affecting the nuclear localization of the protein, as calcium signals are known to influence the transport of molecules between the cytoplasm and nucleus.
Moreover, Hunchback activators may also include compounds that influence the degradation pathways of the protein. Proteasome, for example, could lead to an accumulation of Hunchback by reducing its degradation, thereby indirectly increasing the functional concentration of the protein within the cell. Another class of activators might affect the upstream signaling pathways that regulate Hunchback's activity, such as those involving molecules that modulate the gradient of morphogens known to influence Hunchback's spatial expression patterns. By fine-tuning these morphogen gradients, these chemicals would indirectly affect the activity of Hunchback by altering the cellular context in which it operates. It is important to note that the efficacy of these activators is contingent upon their ability to selectively interact with the pathways pertinent to Hunchback's role in transcription regulation, ensuring that the protein's activity is enhanced in a manner that is congruent with its biological function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased levels of cyclic AMP (cAMP). Elevated cAMP activates PKA (Protein Kinase A), which can phosphorylate transcription factors and coactivators associated with the hunchback gene, thus enhancing hunchback protein activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, which could reduce methylation at the hunchback gene promoter, leading to its increased expression and subsequent rise in hunchback protein activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
As a DNA methyltransferase inhibitor, 5-Aza-2'-deoxycytidine causes hypomethylation of DNA, which can lead to increased expression of the hunchback gene, thereby enhancing the hunchback protein's functional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to retinoic acid receptors which can interact with the promoter regions of genes including hunchback, leading to an upregulation of its expression and increased protein activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C (PKC) which can lead to the phosphorylation of transcription factors that enhance the transcription of the hunchback gene, increasing hunchback protein activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate is an HDAC inhibitor that can lead to hyperacetylation of histones near the hunchback gene, facilitating an open chromatin state and potentially enhancing hunchback transcription. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $37.00 $47.00 | ||
Kinetin is known to influence gene transcription and could enhance the transcription of hunchback by affecting transcription factor binding or chromatin remodeling at the hunchback gene locus. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol activates sirtuin proteins, which are involved in the deacetylation of histones. This can lead to changes in gene expression profiles, including the potential upregulation of hunchback. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $126.00 $278.00 $984.00 | 3 | |
Zebularine is a cytidine analog that inhibits DNA methylation. Reduced methylation on the hunchback gene could lead to its increased expression and enhanced hunchback protein activity. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane has been shown to affect histone acetylation and methylation, which could lead to an increase in hunchback gene expression and subsequent hunchback protein activation. | ||||||